<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">42390</article-id><article-id pub-id-type="doi">10.7554/eLife.42390</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>A mechanistic model for long-term immunological outcomes in South African HIV-infected children and adults receiving ART</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-115989"><name><surname>Ujeneza</surname><given-names>Eva Liliane</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5760-4847</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-125207"><name><surname>Ndifon</surname><given-names>Wilfred</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-125208"><name><surname>Shawry</surname><given-names>Shobna</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-125209"><name><surname>Fatti</surname><given-names>Geoffrey</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6467-662X</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-125210"><name><surname>Riou</surname><given-names>Julien</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-125212"><name><surname>Davies</surname><given-names>Mary-Ann</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-125211"><name><surname>Nieuwoudt</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><collab>IeDEA-Southern Africa collaboration</collab></contrib><aff id="aff1"><institution content-type="dept">DST/NRF South African Center for Epidemiological Modelling and Analysis (SACEMA), Mathematics</institution>, <institution>Stellenbosch University</institution>, <addr-line><named-content content-type="city">Stellenbosch</named-content></addr-line>, <country>South Africa</country></aff><aff id="aff2"><institution content-type="dept">Research</institution>, <institution>African Institute for Mathematical Sciences Next Einstein Initiative</institution>, <addr-line><named-content content-type="city">Kigali</named-content></addr-line>, <country>Rwanda</country></aff><aff id="aff3"><institution content-type="dept">Wits Reproductive Health and HIV Institute</institution>, <institution>University of the Witwatersrand</institution>, <addr-line><named-content content-type="city">Johannesburg</named-content></addr-line>, <country>South Africa</country></aff><aff id="aff4"><institution content-type="dept">Research</institution>, <institution>Kheth'Impilo AIDS Free Living, Division of Epidemiology and Biostatistics</institution>, <addr-line><named-content content-type="city">Cape Town</named-content></addr-line>, <country>South Africa</country></aff><aff id="aff5"><institution content-type="dept">Institute of Social and Preventive Medicine</institution>, <institution>University of Bern</institution>, <addr-line><named-content content-type="city">Bern</named-content></addr-line>, <country>Switzerland</country></aff><aff id="aff6"><institution content-type="dept">Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine and Family Medecine</institution>, <institution>University of Cape Town</institution>, <addr-line><named-content content-type="city">Cape  Town</named-content></addr-line>, <country>South Africa</country></aff><aff id="aff7"><institution content-type="dept">DST/NRF South African Center for Epidemiological Modelling and Analysis, Institute for Biomedical Engineering (IBE)</institution>, <institution>Stellenbosch University</institution>, <addr-line><named-content content-type="city">Stellenbosch</named-content></addr-line>, <country>South Africa</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-10362"><name><surname>Davenport</surname><given-names>Miles P</given-names></name><role>Reviewing editor</role><aff><institution>University of New South Wales</institution>, <country>Australia</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>ujeneva@gmail.com</email> (EU);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>14</day><month>01</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e42390</elocation-id><history><date date-type="received"><day>27</day><month>09</month><year>2018</year></date><date date-type="accepted"><day>13</day><month>01</month><year>2021</year></date></history><permissions><copyright-statement>Â© 2021, Ujeneza et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Ujeneza et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-42390-v1.pdf"/><abstract><p>Long-term effects of the growing population of HIV-treated people in Southern Africa on individuals and the public health sector at large are not yet understood. This study proposes a novel 'ratio' model that relates CD4+ T-cell counts of HIV-infected individuals to the CD4+ count reference values from healthy populations. We use mixed-effects regression to fit the model to data from 1,616 children (median age 4.3 years at ART initiation) and 14,542 adults (median age 36 years at ART initiation). We found that the scaled carrying capacity, maximum CD4+ count relative to an HIV-negative individual of similar age, and baseline scaled CD4+ counts were closer to healthy values in children than in adults. Post-ART initiation, CD4+ growth rate was inversely correlated with baseline CD4+ T-cell counts, and consequently higher in adults than children. Our results highlight the impacts of age on dynamics of the immune system of healthy and HIV-infected individuals.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100002322</institution-id><institution>Schlumberger Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Ujeneza</surname><given-names>Eva Liliane</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>South African Department of Science and Technology and the National Research Foundation&amp;apos;s  Center of Excellence for Modelling and Analysis of Epidemiological Data</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Ujeneza</surname><given-names>Eva Liliane</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number</institution></institution-wrap></funding-source><award-id>U01AI069924</award-id><principal-award-recipient><name><surname>Davies</surname><given-names>Mary-Ann</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: This study was approved as part of the IeDEA Southern African collaboration's protocol, by the Human Research Ethics Committee of the University of Cape Town, with a reference number N1810119 RECIP UCT 084/2006. Informed consent was obtained from all participants by the clinics collecting the data according to IeDEA protocols.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Data used is from the International epidemiologic Databases to Evaluate AIDS Southern Africa collaboration. They maintain a database of routinely collected data from various clinics , mostly located in South Africa. We recommend that interested readers contact Dr. Morna Cornell, Project Manager IeDEA-SA in Cape Town (morna.cornell@uct.ac.za) to establish a data-sharing agreement. A research proposal highlighting how the data will be used is required.Source data for Figures / Figure supplements are provided and the Source code is available via GitHub.</p></sec><supplementary-material><ext-link xlink:href="elife-42390-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>